×
About 393 results

ALLMedicine™ Breast Cancer Chemotherapy Center

Research & Reviews  119 results

Gonadotropin-releasing hormone agonists for ovarian protection during breast cancer che...
https://doi.org/10.1097/GME.0000000000002019
Menopause (New York, N.Y.); Li ZY, Dong YL et. al.

Aug 3rd, 2022 - The increasing trend of delaying childbirth means that more women are being diagnosed with breast cancer before having given birth to their desired number of children. Although chemotherapy can significantly improve the prognosis of this populatio...

Glucose deprivation reduces proliferation and motility, and enhances the anti-prolifera...
https://doi.org/10.1371/journal.pone.0272449
PloS One; Khajah MA, Khushaish S et. al.

Aug 3rd, 2022 - Breast cancer chemotherapy with high dose alkylating agents is severely limited by their collateral toxicity to crucial normal tissues such as immune and gut cells. Taking advantage of the selective dependence of cancer cells on high glucose and c...

All-extremity Exercise During Breast Cancer Chemotherapy
https://clinicaltrials.gov/ct2/show/NCT04914663

Jun 30th, 2022 - Currently, there are 3.5 million breast cancer survivors in the United States and this number is expected to increase dramatically. The proposed research will examine whether a novel exercise intervention for breast cancer patients who are undergo...

Novel Radiomic Measurements of Tumor-Associated Vasculature Morphology on Clinical Imag...
https://doi.org/10.1158/1078-0432.CCR-21-4148
Clinical Cancer Research : an Official Journal of the Ame... Braman N, Prasanna P et. al.

Jun 22nd, 2022 - Tumor-associated vasculature is distinguished its convolutedness, leakiness, and chaotic architecture, which facilitates the creation of a treatment resistant tumor microenvironment. Measurable differences in these attributes might help stratify p...

Breast cancer chemotherapy induces vascular dysfunction and hypertension through a NOX4...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9246378
The Journal of Clinical Investigation; Szczepaniak P, Siedlinski M et. al.

May 27th, 2022 - Cardiovascular disease is the major cause of morbidity and mortality in breast cancer survivors. Chemotherapy contributes to this risk. We aimed to define the mechanisms of long-term vascular dysfunction caused by neoadjuvant chemotherapy (NACT) a...

see more →

Clinicaltrials.gov  20 results

All-extremity Exercise During Breast Cancer Chemotherapy
https://clinicaltrials.gov/ct2/show/NCT04914663

Jun 30th, 2022 - Currently, there are 3.5 million breast cancer survivors in the United States and this number is expected to increase dramatically. The proposed research will examine whether a novel exercise intervention for breast cancer patients who are undergo...

Pantoprazole Prophylaxis Against Delayed CINV for Patients Receiving Breast Cancer Chemotherapy
https://clinicaltrials.gov/ct2/show/NCT03948477

May 25th, 2022 - Breast Cancer is the most common cancer type in women in New Zealand and has the second highest mortality (Ministry of Health NZ) Many women with early breast cancer still receive chemotherapy, before or after surgery and delayed nausea is a parti...

Netupitant/Palonosetron Hydrochloride and Dexamethasone With or Without Prochlorperazine or Olanzapine in Improving Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer
https://clinicaltrials.gov/ct2/show/NCT03367572

May 19th, 2022 - PRIMARY OBJECTIVES: I. To determine if control of nausea at cycle 2 in participants who experienced chemotherapy-induced nausea and vomiting (CINV) at cycle 1 is improved by the addition of either prochlorperazine or olanzapine to the control arm ...

Impact of Home-based Aerobic and Strength Exercises During Chemotherapy for Early Breast Cancer on Biomarkers of Aging
https://clinicaltrials.gov/ct2/show/NCT03761706

Mar 22nd, 2022 - The overall focus of this study remains the investigation of associations between p16 and assessments (independent and patient-reported) of chemotherapy-related toxicity (adverse events and symptoms) and patient-reported measures of function and q...

Injection Regimen Trial of PEG-rhG-CSF During Breast Cancer Chemotherapy
https://clinicaltrials.gov/ct2/show/NCT04477616

Jul 22nd, 2021 - The purpose of this study is to try to find a better injection regimen (including time and dose) of PEG-rhG-CSF, which is supposed to better prevent bone marrow suppression and/or FN in breast cancer patients who receive chemotherapy.

see more →

News  18 results

Dermatology Expert Discusses Challenges Facing Cancer Patients
https://www.onclive.com/view/dermatology-expert-discusses-challenges-facing-cancer-patients

Oct 6th, 2021 - Mario E. Lacouture, MD Dermatologist Memorial Sloan-Kettering Cancer Center New York, NY Skin conditions can affect patients throughout their cancer trajectory, emerging or persisting even after treatment ends. Novel therapies als...

New Data Strengthen Case for Prechemotherapy Statins
https://www.medscape.com/viewarticle/943695

Jan 6th, 2021 - Evidence supporting the use of statins to protect against cardiotoxic chemotherapy has been strengthened with new data from a propensity-matched analysis. Among women with breast cancer treated with anthracycline chemotherapy, statins were associa...

Dosing for Obesity New Chemotherapy Guidelines Linked to Body Weight
https://www.onclive.com/view/dosing-for-obesity-new-chemotherapy-guidelines-linked-to-body-weight

Dec 5th, 2020 - Martha Polovich, PhD, RN, AOCN® In the course of an average day, a medical oncologist may have to break terrible news to several patients, telling them they have cancer, or that their disease has recurred. In comparison, sitting down in a quie...

Chemobrain-It's Real, It's Complex, and the Science Is Still Evolving
https://www.onclive.com/view/chemobrainits-real-its-complex-and-the-science-is-still-evolving

Dec 4th, 2020 - Susan Krigel, PhD Talk with almost any cancer survivor, and she is likely to bring up the topic of chemobrain, that fuzzy, murky state that patients blame for impaired memory. When you first began hearing patients complain about chemobrain, you m...

Studies Confirm Rolapitant Reduces CINV in Breast and Gynecologic Cancers
https://www.onclive.com/view/studies-confirm-rolapitant-reduces-cinv-in-breast-and-gynecologic-cancers

Nov 13th, 2020 - Lee Schwartzberg, MD Additional findings from 2 studies of rolapitant (Varubi) for the prevention of chemotherapy-induced nausea and vomiting (CINV) are providing further evidence of the efficacy of the long-acting NK-1 receptor antagonist. The r...

see more →